CTRI Number |
CTRI/2022/09/045813 [Registered on: 23/09/2022] Trial Registered Prospectively |
Last Modified On: |
07/09/2022 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
A study on dexmethasone as an adjuvant to 0.2% Ropivacaine in USG guided preemptive caudal epidural block for peri operative analgesia in patients undergoing lumbar spine surgeries |
Scientific Title of Study
|
A Comparative study on Dexamethasone as an adjuvant to 0.2% Ropivacaine in USG Guided Pre-Emptive Caudal Epidural block for perioperative analgesia in patients undergoing degenerative lumbar spine surgeries |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Swati Bisht |
Designation |
Professor Anesthesia |
Affiliation |
Vydehi institute of medical sciences and research centre |
Address |
Vydehi medical college,
Whitefield,
Bengaluru- 560066
Bangalore KARNATAKA 560066 India |
Phone |
9880463983 |
Fax |
|
Email |
swatibisht1199@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Sitara A Y |
Designation |
PG Anesthesia |
Affiliation |
Vydehi institute of medical sciences and research centre |
Address |
Vydehi medical college,
Whitefield,
Bengaluru
Bangalore KARNATAKA 560066 India |
Phone |
9902096666 |
Fax |
|
Email |
drsitaraay@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Sitara A Y |
Designation |
PG Anesthesia |
Affiliation |
Vydehi institute of medical sciences and research centre |
Address |
Vydehi medical college,
Whitefield,
Bengaluru
Bangalore KARNATAKA 560066 India |
Phone |
9902096666 |
Fax |
|
Email |
drsitaraay@gmail.com |
|
Source of Monetary or Material Support
|
Vydehi institute of medical sciences and research centre |
|
Primary Sponsor
|
Name |
Dr Sitara A Y |
Address |
Vydehi medical college,
Whitefield,
Bengaluru. |
Type of Sponsor |
Other [SELF] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Sitara |
Vydehi institute of medical sciences and research centre |
Department of anaesthesiology
First floor
Nallurhalli main road, near BMTC 18th Depot, Vijayanagar, Whitefield.
Bengaluru 560066 Bangalore KARNATAKA |
9902096666
drsitaraay@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Vydehi institutional ethics committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: 3||Administration, (2) ICD-10 Condition: 3||Administration, (3) ICD-10 Condition: 3||Administration, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Caudal epidural block in patients undergoing degenerative lumbar spine surgeries |
Inj Ropivacaine 0.2% with Inj Dexamethasone 8mg used for caudal epidural block |
Intervention |
Inj Ropivacaine |
Single shot Inj Ropivacaine 0.2% used for adult caudal epidural block |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
65.00 Year(s) |
Gender |
Both |
Details |
1.Patients belonging to ASA I,II.
2. Patients who give informed written consent. |
|
ExclusionCriteria |
Details |
1.Patients refusal for study, patients who underwent a previous lumbar spine surgery
2. Patients with a contraindication to regional anaesthesia
3. Patients with hypersensitivity to ropivacaine.
4. Patients with known cardiac, renal, hepatic, neurological disorders that would interfere with cardiovascular response assessment.
5. Patients with spine abnormalities and body dysmorphism.
6. Patients with coagulopathy or on any anti coagulants.
7. Use of benzodiazepines, anticonvulsants, alcohol, opioids or other psychotropic drugs. |
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Double Blind Double Dummy |
Primary Outcome
|
Outcome |
TimePoints |
To compare intraoperative opioid consumption
To compare duration of analgesia |
6-48hrs |
|
Secondary Outcome
|
Outcome |
TimePoints |
To compare the hemodynamic changes
To compare adverse effects |
6-48hrs |
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2/ Phase 3 |
Date of First Enrollment (India)
|
30/09/2022 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="5" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
This study is a randomized, double blind, parallel group, trial comparing the safety and efficacy of Ropivacaine 0.2% and Ropivacaine 0.2% with Inj Dexamethasone 8mg in 50 patients undergoing lumbar spine surgery that will be conducted in Vydehi medical college and research centre in India. The primary outcome measures will be opioid consumption between the 2 groups and Duration and efficacy of analgesia between the group. The secondary outcomes will be hemodynamic changes in the peri operative period between the group and adverse effects like nausea, vomiting, dowsiness, sedation in post operative period between the two group. |